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Recently, some attention has been focused on acquired stuttering, disfluencies that begin 
in adulthood. The nature of acquired stuttering differs in several respects from developmental 
stuttering. A case of acquired stuttering following drug overdose is presented and contrasted 
with previously reported cases. The case is noteworthy in that, while many characteristics 
of acquired stuttering are evidenced, several symptoms associated with developmental stut- 
tering are also observed. The findings are discussed in terms of a possible link between 
developmental and acquired forms of stuttering. 
INTRODUCTION 
Many researchers suggest it is likely that there are multiple etiologies of 
stuttering and that stutterers do not represent a homogeneous population. 
Some have proposed different types of stutterers (Van Riper, 1971; Riley 
and Riley, 1980). However, these groupings are not always easily distin- 
guished, and there is lack of agreement on the delineations. Consequently, 
there has not been a universally adopted system of classification. One 
subgroup of stutterers, however, is distinguished with relative ease: those 
whose disfluencies begin in adulthood, generally referred to as “acquired 
stutterers.” It is the intent of this paper to survey the literature on acquired 
stuttering, provide a review of selected drugs that interrupt speech 
fluency, and present a case report of acquired stuttering whose charac- 
teristics differ markedly from previous case reports. 
A body of case reports and studies on acquired stuttering is beginning 
to amass. Close examination of the literature addressing acquired stut- 
tering reveals considerable overlap and inconsistency in terminology; neu- 
rologic stuttering, acquired stuttering, neurologic stammering, neurogenic 
stuttering, and cortical stuttering represent a few of the most frequently 
used terms. Subclassifications within these categories further complicate 
comparisons across studies. Comparison of carefully documented case 
studies is essential at this level of our understanding of the disorder. 
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Before reviewing the characteristics of acquired stuttering, the terms 
listed herein will be examined in an attempt to clarify their meaning and 
usage. “Acquired stuttering” is perhaps the most general term, referring 
to stuttering that follows cerebral lesions of traumatic or vascular etiology 
involving the left hemisphere (Mazzucchi et al., 1981). Mazzucchi et al. 
categorized acquired stuttering into three subtypes as follows: 
1. Stuttering associated with signs of language impairment (aphasia) 
2. Isolated stuttering: stuttering not associated with language impair- 
ment or neuropsychologic abnormalities 
3. Preexistent mild stuttering: marked worsening of preexistent de- 
velopmental stuttering following neurologic damage 
Quinn and Andrews (1977) use “neurological stuttering,” to refer to 
two forms of acquired stuttering associated with neurologic pathology. 
The investigators suggest “that stuttering may be a presenting symptom 
of progressive neurological disease . . . [and] . . . that a speech disorder 
indistinguishable from common (developmental) stuttering may follow 
cerebral injury in adulthood” (p. 699). 
“Neurological stammering” has been used to describe stuttering fol- 
lowing severe closed head injury (Inglis, 1979). The patient had no pre- 
morbid history of speech disorder, and presented initial mild-moderate 
dysphasia following the accident. 
Canter (1971) used the term “neurogenic stuttering” to refer to stut- 
tering that results from CNS damage, and suggested three subclasses, as 
follows: 
1. Apraxic stuttering: stuttering as a result of damage to brain centers 
involved in motor programming 
2. Dysarthric stuttering: stuttering as a result of faulty motor execution 
3. Dysnomic stuttering: characterized by dysfluencies due to word 
lapses, as in aphasic syndromes 
“Cortical stuttering” refers to stuttering “resulting from hemispheric, 
although not necessarily cortical, lesions in which deficits in bilaterally 
innervated brain mechanisms produce stuttering symptoms” (Rosenbek 
et al., 1978, p. 93). 
Although most researchers are in agreement concerning stuttering be- 
havior in the presence of neurologic damage, some additional factors 
serve to confound comparisons. For example, some include previously 
developmental stutterers as a subgroup (Mazzucchi et al., 1981), while 
they are excluded by others (Rosenfield, 1972); still others fail to address 
the issue at all. Some researchers underscore the importance of distin- 
guishing acquired stuttering concomitant with language impairment from 
isolated acquired stuttering (Mazzucchi et al., 1981); others (Canter, 1971) 
do not make a distinction. Motor problems associated with neurologic 
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impairment, dysarthria, and apraxia (Canter, 1971) represent an added 
factor. 
It is evident that neurologic damage that affects speech may result in 
many forms of impairments. In attempting to synthesize the literature, 
four distinctions appear to represent significant delineations of acquired 
stuttering in terms of effecting disfluencies: 
1. Stuttering concomitant with language impairment: impaired lan- 
guage and word-finding abilities associated with aphasia and neu- 
rologic impairment that affect the fluency of speech 
2. Stuttering associated with motor speech impairment-the results of 
damage to motor programming centers of the brain or the inability 
to execute speech patterns; 
3. Recurrence of stuttering in individuals having experienced recovery 
from developmental stuttering; 
4. Isolated acquired stuttering-individuals experiencing disfluencies 
in the absence of language or motor impairment, who never previ- 
ously stuttered. 
CHARACTERISTICS OF ACQUIRED STUTTERING 
In order to generate a list of characteristic behaviors of acquired stut- 
tering, it is necessary to identify the behaviors that pertain to each def- 
inition of the disorder. Table 1 displays the characteristics of acquired 
stuttering along the following dimensions: 
1. Speech behaviors: features of speech identified in the literature as 
characterizing acquired stuttering; the presence or absence of each 
characteristic from reports in the literature is indicated by (+) for 
the presence of the behavior and by ( -) for the absence of the 
behavior in the subjects observed. Those behaviors specifically cited 
as characteristic of isolated stuttering are entered with ( + +) or 
(- -). No entry indicates that no mention of the item was made in 
the study. 
2. Speech alterations: procedural or speaking conditions reported in 
the literature (e.g., delayed auditory feedback, miming). Case re- 
ports were examined for the presence or absence of these alterations, 
and a similar sign system was employed. 
Examination of Table 1 indicates that many characteristics are observed 
overall, yet no single behavior is noted in every study, nor does any single 
study evidence every behavior. The result is a somewhat sketchy picture 
of the speech behaviors of acquired stuttering. 
Looking specifically at features associated with cases of isolated stut- 
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one of the studies. When examining the features found in three or more 
studies, the following characteristics emerge: (a) absence of the adaptation 
effect; (b) initial and medial syllable repetition; (c) prolongations; (d) pres- 
ence of secondaries; (e) lack of improvement in singing; and (f) lack of 
improvement in choral reading. It is difficult to characterize the subgroup 
of isolated acquired stuttering due to inconsistency of features examined 
across studies. In addition, features that have been examined are difficult 
to compare because various subgroups of acquired stuttering have been 
combined in several studies. 
Several cases of acquired stuttering secondary to brain damage have 
been reported in the literature (Arend, Handzel, and Weiss, 1962; Jones, 
1966; Borkowski, Benton, and Spreen, 1967; Canter, 1971; Caplan, 1972; 
Rosenfield, 1972; Fal-met-, 1975; Helm, Butler, and Benson, 1978; Ro- 
senbek et al., 1978; Donnan, 1979; Rosenfield, Miller, and Feltovich, 
1980). Most reports indicated stuttering to be concurrent with language 
impairment. 
Helm et al. (1978) summarized five features that characterized their 
patients: 
1. Absence of the adaptation effect 
2. Repetitions, prolongation, and blocks not restricted to initial sylla- 
bles 
3. Disfluencies on small grammatical words, as well as substantive 
words 
4. Speaker does not appear to be anxious 
5. Secondary symptomatology rarely observed 
Two additional features were noted by Canter (1971), whose patients 
exhibited particular difficulty with the phonemes /r/, ill, and /h/, and were 
more disfluent in choral speaking than self-formulated speech. However, 
Helm et al. (1978) did not note these features to be characteristic of their 
patients. 
Helm et al. (1980) report that the acquired stutterers they evaluated 
evidenced one or more of certain characteristics on their battery of neu- 
ropsychologic tests, including: (a) difficulty drawing three-dimensional 
figures; (b) difficulty copying block designs; (c) difficulty reproducing 
alternating sequential hand positions; (d) difficulty singing melodies; and 
(e) difftculty reproducing tapping patterns. The investigators further noted 
that “patients with persistent stuttering tended to have difficulty with all 
of the above tasks, [while] the patients with transient stuttering of vascular 
origin tended to have difticulty with only the first three tasks” (p. 277). 
The sex ratio in developmental stuttering is generally accepted to be 
about 3 : 1 (M : F) among school-age children, increasing to nearly 8 : I in 
adulthood (Bloodstein, 1981). This increase is largely explained by the 
higher percentage of females apparently recovering from their fluency 
270 G. J. RENTSCHLER et al. 
Table 2. Sex Ratio in Acquired Stuttering 
Source (reference) Males : Female 
Andrews et al. (1972) l:o 
Rosenfield (1972) 0:l 
Quinn and Andrews (1977) 2:o 
Helm et al. (1978) 9:1 
Rosenbek et al. (1978)” 7:o 
Mazzucchi et al. (1981) 15:l 
Rosenfield et al. (1981) I:0 
Deal (1982)” I:0 
Present study I:0 
Total 37:3 
Ratio 12.3: I 
a Reported from Veteran’s Administration Hospital populations. 
difficulties. Information regarding sex ratio and recovery in acquired stut- 
tering is presented in Tables 2 and 3. 
Table 2 displays the cumulative sex ratios reported in the literature. As 
is shown, the sex ratio in acquired stuttering appears to be about 12: 1 
(M : F). It should be noted that one possible source of error is that several 
studies were reported from Veterans Administration Hospital popula- 
tions, representing a predominately male population. 
In a review of a number of studies, Bloodstein (1981) reported that the 
percentage of developmental stutterers who experience recovery ranges 
from 36% to 79%. Recovery among acquired stutterers (Table 3) appears 
to be less frequent. Information compiled from several case reports re- 
veals that 29.4% (10/34) of acquired stutterers experience remission of 
their disfluencies. Helm et al. (1980) suggest that recovery (transient ac- 
quired stuttering) is associated with multifocal lesions in the left hemi- 
Table 3. Recovery from Acquired Stuttering 
Number of 
cases 
Source (reference) recovered 
Andrews et al. (1972) 0 
Rosenfield (1972) 1 
Helm et al. (1978) 2 
Rosenbek et al. (1978) 2 
Mazzucchi et al. (1981) 4 
Rosenfield et al. (1981) 0 
Deal ( 1982) I 
Present study 0 
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sphere (language dominant), while persistent stuttering is associated with 
bilateral neurologic damage (resulting from cerebral disease or trauma). 
Some studies have had difficulty separating language impairment, dy- 
sarthria, and disfluency. Rosenfield’s (1972) patient and two of Rosenbek 
et al’s (1978) subjects stuttered in the absence of language impairment. 
Cases of acquired stuttering concomitant with language impairment, in- 
deed, are complicated by the supposition that disrupted language may be 
intimately involved in the etiology of the disfluencies. Investigations of 
developmental stuttering suggest that some stutterers may have a lan- 
guage delay or disorder concomitant with their stuttering (Gregory and 
Hill, 1980; Riley and Riley, 1980). Certainly cases of acquired stuttering 
in the absence of language involvement present the opportunity to in- 
vestigate the disorder with less likelihood of an interaction effect. How- 
ever, the close association between cerebral injury and language impair- 
ment is well known. Some reported cases observed disfluencies after 
language impairment had subsided. Andrews, Quinn, and Sorby (1972) 
reported patients whose stuttering persisted at least 4 yr after aphasia had 
resolved. 
SELECTED DRUGS AFFECTING SPEECH 
Language and speech function often index the effects of a variety of dis- 
orders, including drug toxicity (Darby, 1981). Few investigations have 
systematically examined the effects of commonly used drugs on speech 
and language performance. Recent findings suggest that certain drugs may 
alter neurologic function affecting abnormal speech and/or language be- 
haviors. 
Single doses of benzodiazepine derivatives, such as Tranxene and Li 
brium, have been observed to adversely alter cognitive functioning and 
speech behavior (Gottschalk, 1977). In a double-blind study, several ben- 
zodiazepine derivatives were administered to subjects. Five-minute 
speech samples were collected before and 30-300 min after administration 
of single doses of chlorodiazapoxide (Librium, 25 mg/orally), Lorazepan 
(3 and 5 mg i.m.; and 2 and 5 mg i.v.), Triazolam (0.25-2.0 mg/orally) 
and Flurazepam (30 mg/day/orally, and Lorazepam (3 mg/day/orally). An 
analysis to assess the psychologic and cognitive/intellectual effects of the 
drug was done before and during treatment. Results indicated that ben- 
zodiazepine derivatives (taken in daily therapeutic dosage) had temporary 
adverse affects on cognitive functioning. Measurements were made of 
objective content analysis of 5-min speech samples following administra- 
tion of the drugs. The following speech behaviors were consistently ev- 
ident: blocking or use of incomplete sentences and phrases; repetition of 
words in sequence; and inaudible or unintelligible speech. These tindings 
are significant in that they suggest that therapeutic dosages of benzodi- 
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azepine derivative drugs may reduce cognitive, intellectual, and speech 
functioning. 
Tricyclics are used widely in the treatment of depression. Side effects 
commonly reported include dry mouth, tremor, dizziness, tachycardia, 
blurred vision, and urinary retention. Shatzberg, Cole, and Blumer (1978) 
suggested that tricyclic drugs also may have an adverse effect on memory 
and speech production. They reported that patients experienced a halting 
in normal speech patterns lasting from 1 to 3 sec. Tricyclics administered 
in both therapeutic and large doses (300-400 mg/day) have been reported 
to produce dysarthria similar to stuttering (Saunders, 1977; Quader, 1977). 
Normal speech returned within 2 days after the drug was discontinued. 
Chronic usage of some antipsychotic drugs has resulted in the devel- 
opment of tardive dyskinesia, and may produce speech alterations that 
are characteristic of dysphonia and involve articulation, phonation, res- 
onance, and prosodic components of speech production (Darley, Aron- 
son, and Brown, 1975; Gawel, 1981). 
Lithium is a commonly indicated treatment for manic-depressive ill- 
ness. It is well established that the therapeutic level for Lithium is very 
close to the level that is toxic. A growing number of reports have described 
patients who developed severe Lithium neurotoxicity with normal serum 
Lithium concentration. This phenomenon has been investigated by sev- 
eral researchers (Bond, Carhalho, and Foulks, 1982; Newport and Saun- 
ders, 1979; Speir and Hirsh, 1978; West and Meltzer, 1979). Based on 
their conclusions, some have suggested that increased vulnerability to the 
occurrence of severe Lithium neurotoxicity may be due to the patient’s 
intense anxiety (West and Meltzer, 1979). preexisting brain damage (Ap- 
plebaum, Shader, Funkenstein and Henson, 1979), or to changes in RBC 
Lithium concentration and RBCiplasma Lithium ratio (Elizur, Shipsin, 
and Gershon, 1972). 
Based on a study using psychotic patients, Applebaum et al. (1979) 
suggested that Lithium toxicity produced ataxia, dysarthria, slurred 
speech, and progressive onset of confusion. These findings are consistent 
with other studies that report the occurrence of speech disorders related 
to Lithium carbonate toxicity at therapeutic levels (Edgell. Peterty, and 
Pinter, 1970; Melia, 1970; Soloman and Vickers. 1975). 
Bond et al. (1982) recently reported a lPyr-old manic-depressive pa- 
tient who developed persistent dysarthria with apraxia while receiving a 
combination of high-dose Haloperidol (SO mg/day) and Lithium carbonate 
(1500 mg/day). After approximately 6 wk of treatment, the patient’s 
speech became slurred and intelligibility decreased. This drug treatment 
was discontinued after which the patient was given Thordiazine (100 mgi 
day, increased to 400 mgiday). The patient’s speech became intermittently 
unintelligible. Thordiazine was discontinued and Chlorpromazine (600 
mg/day) was initiated. Even though this dosage was gradually reduced 
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over the next 2-wk period, the patient continued to exhibit severe speech 
difficulties. A speech evaluation conducted at this time indicated that the 
patient “demonstrated a marked speech problem characterized by re- 
duced intelligibility varying from mildly reduced in single word production 
to severely reduced in connected speech.” Diadochokinetic production 
was slow, irregular, and slurred. An oral-motor examination indicated 
deficiencies in lingual elevation, which correlated with the patient’s ar- 
ticulation errors and slurred speech. Concurrent with these findings, 
Spring (1979) reported that a combination of Thoridiazine and Lithium 
(serum level 0.9 mg/L) produced confusion, slurred speech, and affected 
memory in a 61 yr-old manic-depressive patient. 
Based on the assumption that anxiety and tension play a central role 
in precipitating stuttering, pharmaceutical agents (antianxiety and anti- 
depressant drugs) have been indicated in its treatment (Maxwell and Pa- 
terson, 1958; Fish and Bowline, 1962; Leanderson ane Levi, 1967). Agents 
used include Haloperidol, Reserpine, Meprobamate, Chlorpromazine, 
and Thioridazine. Findings related to the efficacy of such treatment, how- 
ever, remain varied and inconclusive. Only Haloperidol has been reported 
to be clinically effective (Quinn and Peachy, 1973; Andrews and Dozsa, 
1977). Effectiveness, however, has not been superior to behavior-oriented 
approaches. Combined with the side effects of Haloperidol, it has not 
been a preferred method in treating stuttering. 
CASE HISTORY 
A case of isolated acquired stuttering following a drug overdose is re- 
ported, which differs significantly from previously reported cases. Mr. 
H. is a 41-yr-old divorced male, formerly employed as a dispatcher for a 
large industrial manufacturer. He was referred for speech evaluation with 
severe disfluencies following a (second) suicide attempt. Mr. H. has a 
history of life crises and has been under psychiatric care since his first 
suicide attempt (overdose of Talwin) in January 1979. The patient was 
treated for manic-depression and acute anxiety. 
Mr. H. overdosed on Tranxene (and possibly Librium) in January 1982. 
The patient reported taking 150 7.5mg capsules of Tranxene and a similar 
amount of Librium. Both Tranxene and Librium have been shown to 
effect disfluencies in speech (as discussed earlier in this paper). The 
amounts of each drug taken, as reported by Mr. H., were questioned by 
the examining medical team due to the alertness of the patient in the 
emergency room. 
Mr. H. remained hospitalized for 2 days. During the course of his stay, 
frequent reference was made in his medical chart to his slurred speech 
and disorientation (especially to time). The grasp of the left hand was 
noted to be weaker than the right, 
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The patient was discharged briefly to a mental hospital after which 
Lithium was prescribed for depression. Four to 5 days following initiation 
of Lithium, Mr. H. began to experience muscle tightness in his throat and 
upper chest, resulting in disfluencies in his speech. As previously noted, 
Lithium has been reported to adversely affect speech, particularly in sub- 
jects with preexisting brain damage. The drug was discontinued, but the 
disfluencies persisted. 
Upon evaluation of his communicative disability (April 1982), the pa- 
tient revealed difficulty retaining information when reading, was unsure 
of the meaning of some words (he carried a pocket dictionary), and re- 
ported word formulation difficulty in speech. These difficulties resolved 
shortly thereafter. 
Initial Characteristics of Disfluencies 
During the initial diagnostic therapy sessions. video and auditory tape 
recordings were made. From notes of the initial session, it was reported 
that disfluencies occurred on almost every word. Difficulty managing the 
breathstream was pronounced; there was a strong breathy component to 
his vocalizations and puffing of the cheeks. Disfluencies were character- 
ized by prolongations and repetitions of sounds and syllables. The pa- 
tient’s total overall score on the Stuttering Severity Instrument (SSI; 
Riley, 1980) was 33, ranking him in the 89th percentile and categorizing 
his stuttering as severe (Table 4). Mr. H. experienced disfluencies on 66% 
of words in conversation and an even higher rate in reading aloud (fre- 
quency task score, 18). The longest disfluencies lasted approximately 20 
set (duration score, 5). Physical concomitant score was evaluated to be 
10 due to the distracting character of his breathiness and head movement 
and very distracting facial grimacing. Blocking was noted at the laryngeal 
and labial levels. Eye contact was poor. The patient reported acute anx- 
iety directly related to his speech and stuttering even when he was alone. 
Disfluencies diminished somewhat in choral speaking, but rhythm (arm 
swing, finger tapping) evidenced only a minimal effect. Continuous phon- 
Table 4. Riley Scores 
Scores 









0 89th percentile. 
b 41st percentile. 
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ation did effect a notable decrease in the severity, but not the frequency 
of his disfluencies. Because of its impact, it was selected as the technique 
to be utilized in therapy. 
Additional Initial Testing 
Mr. H. was referred for neurologic examination in April 1982. The ex- 
amination was unremarkable with the exception of his speech. Dysarthria 
was ruled out. Evidence of organic nervous system disease was not dis- 
covered. A CT scan failed to uncover deep white matter lesions. (Normal 
neurologic and CT scan findings have similarly been revealed in other 
case reports; Helm et al., 1978; Mazzucchi et al., 1981.) 
The Michigan Neuropsychological Test Battery (Smith, 1975) was first 
administered in May 1982 for purposes of evaluating motor and cognitive 
functioning, and to compare his performance with neuropsychologic tind- 
ings from other reported cases of acquired stuttering. The patient’s profile 
indicated organic bilateral cerebral dysfunction with greater involvement 
of right hemispheric (nonverbal cognitive) then left hemispheric (verbal 
cognitive) function. Test scores are displayed in Table 5. The Block De- 
sign subtest score was particularly depressed relative to other subtests, 
but fell in the borderline defective range. Depressed Block Design scores 
were reported by Helm et al. (1978) to be a characteristic feature in ac- 
quired stuttering. The patient demonstrated only slight difficulty copying 
three-dimensional drawings; similarly, repeating rhythmic tapping se- 
quences or melody patterns appeared only mildly affected. 
Transitions 
Mr. H. discontinued therapy after a few sessions to enable himself to put 
other personal matters in order. The patient was reexamined in November 
1982, approximately 11 mo following the initial episode. Upon reexami- 
nation Mr. H. evidenced some improvements in his speech. The SSI was 
readministered and categorized Mr. H.‘s problem as moderate (score, 
25), ranking him in the 41st percentile (Table 4). The frequency of dis- 
fluencies underwent a significant decrease; 48% in conversation and 38% 
in reading. However, because these scores remained in the uppermost 
category, the frequency task score was unchanged. The duration of his 
longest blocks diminished to 1 full set (score, 3). Physical concomitants 
decreased to 4 as his grimacing and head movements reduced markedly. 
The breathy, discoordinated phonation lessened but remained noticeable. 
The Neuropsychological Battery was readministered in order to eval- 
uate changes in neuropsychologic functioning (Table 5). WAIS-R IQs 
were significantly lower than those obtained 6 mo earlier, showing de- 
clines of 19, 12, and 16 points in verbal, performance, and full scale IQ 
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Table 5. Scores on Neuropsychologic Test Battery Measures 
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scores, respectively. Abnormal inter- and intratest scatter was reported. 
Block Design scores decreased from a scaled score of 7 to 4 (in the 2nd 
percentile). The erratic pattern of gains and declines was interpreted to 
“reflect the persisting effects of brain insult as well as a continuing process 
of gradual, spontaneous reorganization and recovery of cerebral func- 
tion.“’ 
Table 6 compares Mr. H. with the neuropsychologic features reported 
to be characteristic of acquired stutterers by Helm et al. (1980). The present 
case strongly evidenced two of the signs (block design and singing), and 
had a slight impairment in two other areas (drawing three-dimensional 
figures and tapping patterns), while a fifth feature was not tested. 
’ A. Smith. test report 1982. 
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Table 6. Neuropsychologic Characteristics of Acquired Stuttering 
The presence of one or more of the following 
(Helm, Butler, and Canter, 1980) 
Difftculty drawing three-dimensional figures both 
on command and copying 
Difficulty copying block designs; for example, the 
Block Design Subtest of the WAIS (Wechsler, 
1955) 
Difficulty reproducing and sustaining alternating. 
sequential hand positions; for example, those 
described by Luria (1968) 
Difftculty singing melodies 
Difftculty reproducing rhythmic tapping patterns 






Minimal to no impairment 
Masking 
Mr. H.‘s speech was examined under a condition of white noise masking 
to determine if his disfluencies would decrease significantly (as is typical 
of developmental stutterers). A masking tone was presented binaurally 
while the subject read from a passage. The masking tone was increased 
to 95 dB while the subject read the first 25 words of the passage. After 
reading 21 words at 95 dB, no further disfluencies were evidenced in the 
85 consecutive words that followed, until the intensity level of the masking 
was diminished. This response was considered to be characteristic of 
developmental stutterers and dissimilar to reports of acquired stutterers 
(Shand, 1955; Cherry and Sayers, 1956; Silverman and Goodbar, 1972; 
Trotter and Silverman, 1973). 
Other Phenomena 
Deal (1982) reported a case of stuttering of sudden onset in which the 
subject experienced disfluencies while miming. Perkins et al. (1976) found 
conditions that reduced the complexity of speaking, such as whispering, 
lipping, or miming resulted in significantly fewer (or no) disfluencies. Deal 
suggested that, for his subject, stuttering while miming might “be a sign 
of stuttering subsequent to severe psychological pressure” (p. 304). Mr. 
H. demonstrated no abnormal oral movements when asked to mime a 
reading passage. 
The subject experienced periods of greatly improved fluency. These 
periods were distinctly related to the consumption of alcohol or use of 
marijuana. Disfluencies were reduced, but not absent, presumably be- 
cause of the anxiety-reducing affects of the drugs. 
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DISCUSSION 
This patient is unique in that he reveals characteristics of both devel- 
opmental and acquired stuttering. While the etiology and many clinical 
features of this case are decidedly those of acquired stuttering, the patient 
exhibits many characteristics of developmental stuttering concomitantly. 
Table 7 contrasts selected characteristics associated with different types 
of stuttering and reveals features of both developmental and acquired 
stuttering that the present case evidenced. Mr. H.‘s similarities to de- 
velopmental stuttering included anxiety related to speaking, secondary 
characteristics associated with stuttering, improvement in choral reading, 
and masking. Like acquired stutterers, the present case evidenced no 
adaptation effect, had disfluencies in all word positions and on small gram- 
matic words, as well as substantive words. 
Interestingly, the symptoms manifested by the patient that were similar 
to developmental stuttering could each be related to anxiety, reactions 
to his own speech, or alterations in his ability to monitor his own speech, 
all of which can be associated with psychoperceptual attributes of speak- 
ing and self-monitoring. Because of this and the patient’s psychiatric his- 
tory, it was necessary to attempt to rule out psychogenesis as an etiology 
of the disorder. Helm et al. (1980) discuss psychogenic acquired stuttering 
as a clinical entity; they report symptomotology to include failure to ex- 
hibit neuropsychologic or clinical anatomical abnormalities and variability 
in the occurrence of disfluencies, related to anxiety attacks. On these 
bases, the present case failed to fall within the definition. 
However, the strong psychiatric component should not be easily dis- 
counted. Comparisons with neuropsychologic testing data from other 
studies also found the patient to differ from previously reported group 
data. Cox (1982) compared adult (developmental) stutterers with brain 
damaged and non-brain damaged adult psychotic patients on their neu- 
ropsychologic performances. When compared with the three groups, Mr. 
H. was most similar to the brain damaged psychotic patients (Table 8). 
The comparison is somewhat limited in that only the WAIS scores could 
be contrasted, because of differences in the neuropsychologic test bat- 
teries. Even on this limited basis, however, Mr. H.‘s performance on the 
Block Design subtest (a distinctive feature of acquired stuttering) was 
markedly different. Mr. H. also demonstrated more intersubtest scatter, 
ranging from a low of 4 to a high of 12. Cox’s grouped subjects ranged 
from a low of 7.80 to a high of 10.91. 
Other observations in the literature also tend to diminish the suspicion 
of a psychogenic origin in the present case. Deal (1982, p. 304) reports 
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I) The onset of stuttering is sudden. 
2) The onset is temporally related to a significant event . . which seemed 
to reflect extreme psychological pressure. 
3) The pattern was primarily repetition of initial or stressed syllables. 
4) The pattern was affected little by choral reading, white noise, initial trial 
of delayed auditory feedback, singing and different communicative sit- 
uations. 
51 Initially, the patient had no islands of fluency: even automatic. over- 
learned social responses were stuttered. 
6) Initially, the patient did not express any interest in his stuttering. 
7) The patient did not exhibit secondary symptoms . . did not avoid 
sounds, words, or speaking situations. He appeared to make no attempt 
to inhibit his stuttering in any discernible way. . . 
8) . he evidenced the same patterns of repetitions during mimed reading 
aloud which is not common with developmental stuttering or associated 
with stuttering secondary to brain damage. 
Additionally, Deal’s patient was reported to have been fluent when speak- 
ing to other patients, but nonfluent when speaking to staff members. 
While our patient exhibited many of these features, in particular l-3, 
marked differences can be noted on several parameters. For example, 
the profound affect of masking, the persistent concern regarding his 
speech, the presence of secondary symptoms, and his failure to dem- 
onstrate disfluencies (repetitions) during mimed reading. 
The patient differed from children with developmental stuttering, as 
well. Comparison with scores of 26 stuttering children on the Michigan 
Neuropsychological Test Battery (Rentschler and Liebetrau, 1981) re- 
vealed dissimilarities that were not unlike those seen in comparisons with 
Cox’s (1982) developmental stutterers. While neuropsychologic deficits 
are reported in some stuttering children (Liebetrau and Daly, 1981; 
Rentschler and Liebetrau, 1981), the nature and form of their deficits differ 
from this case of acquired stuttering. 
Several aspects of Mr. H.‘s behaviors were characteristic of devel- 
opmental stuttering, for example the profound effect of masking and the 
dramatic reduction of stuttering evidenced under conditions of perceptual- 
altering drugs. These effects have not been observed to be characteristic 
in other cases of acquired stuttering, but are commonly reported among 
developmental stutterers. 
Two alternatives that attempt to explain the patient’s mix of devel- 
opmental and acquired stuttering characteristics are hypothesized. One 
explanation suggests that there is a strong psychologic overlay to this 
fluency problem, which accounts for the secondaries, anxiety related to 
speaking and the fluency effecting results of reducing those anxieties. This 
explanation, however, fails to account for the neuropsychologic impair- 
ments and other symptoms of acquired stuttering. A second alternative 
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relates more directly to a relationship between organic dysfunction and 
developmental stuttering. This explanation posits that this case may rep- 
resent a link associating some forms of developmental stuttering with 
demonstrable organic dysfunction. In that the patient demonstrates signs 
of organicity and symptoms of developmental stuttering, it would seem 
possible that similar organic dysfunctions may be at the root of some 
developmental stuttering, as well. Cox (1982) pointed out that his adult 
developmental stutterers were unimpaired in their neuropsychologic per- 
formance, while younger (adolescent) samples of stutterers revealed vary- 
ing degrees of impairment. This may suggest that the developmental stut- 
terer may encounter subtle dysfunctions resulting, for example, in 
auditory imperception (Rentschler and Liebetrau, 1981), which serves to 
effect disfluency. Either the subtlety, the developmental nature of the 
dysfunction, or our difficulty in measuring it, may serve to mask it. That 
is to say, the developmental stutterer may learn to be able to compensate 
(in part) for the dysfunction or that the subtlety of the dysfunction may 
conceal it from our as yet imprecise assessment instruments. 
Carrying this hypothesis further, this case may then represent a link 
between organic dysfunction and some forms of developmental stuttering. 
Others have reported the likelihood of subtypes of developmental stut- 
terers and the impact that failing to account for subtypes may have on 
research findings (Rentschler, in press). Thus, at least one subtype may 
be directly related to organic dysfunction. 
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